EPS for Calavo Growers, Inc. (CVGW) Expected At $0.84

May 17, 2018 - By Bradley Stiles

Calavo Growers, Inc. (NASDAQ:CVGW) LogoInvestors sentiment decreased to 1.23 in 2017 Q4. Its down 0.42, from 1.65 in 2017Q3. It worsened, as 11 investors sold Calavo Growers, Inc. shares while 62 reduced holdings. 35 funds opened positions while 55 raised stakes. 15.14 million shares or 2.63% less from 15.54 million shares in 2017Q3 were reported.
First Interstate National Bank stated it has 205 shares. Oppenheimer Asset Mgmt has invested 0.01% in Calavo Growers, Inc. (NASDAQ:CVGW). New Jersey Better Educational Savings Tru reported 3,000 shares. Northern invested in 0.01% or 236,134 shares. Walleye Trading Limited Com has invested 0% in Calavo Growers, Inc. (NASDAQ:CVGW). Parallax Volatility Advisers L P has 2,436 shares for 0% of their portfolio. Barclays Public Limited Co holds 6,942 shares. Blair William Co Il owns 0% invested in Calavo Growers, Inc. (NASDAQ:CVGW) for 5,785 shares. Ameriprise accumulated 94,657 shares. First Republic Invest Mngmt Inc holds 0% or 2,840 shares in its portfolio. Friess Associate Llc stated it has 47,010 shares or 0.33% of all its holdings. Partnervest Advisory Ltd Liability Co holds 0.75% in Calavo Growers, Inc. (NASDAQ:CVGW) or 18,250 shares. State Teachers Retirement Systems, a New York-based fund reported 52,857 shares. The Missouri-based Parkside Financial Bank And has invested 0% in Calavo Growers, Inc. (NASDAQ:CVGW). Texas Permanent School Fund holds 10,666 shares or 0.01% of its portfolio.

Since December 26, 2017, it had 0 buys, and 4 selling transactions for $2.17 million activity. $85,050 worth of Calavo Growers, Inc. (NASDAQ:CVGW) was sold by Brown Marc Laurence on Tuesday, January 2. $692,333 worth of Calavo Growers, Inc. (NASDAQ:CVGW) was sold by LEAVENS J LINK. Browne Michael A sold $598,988 worth of stock or 6,500 shares.

Analysts expect Calavo Growers, Inc. (NASDAQ:CVGW) to report $0.84 EPS on June, 5.They anticipate $0.10 EPS change or 13.51 % from last quarter’s $0.74 EPS. CVGW’s profit would be $14.74M giving it 27.89 P/E if the $0.84 EPS is correct. After having $0.54 EPS previously, Calavo Growers, Inc.’s analysts see 55.56 % EPS growth. The stock decreased 3.05% or $2.95 during the last trading session, reaching $93.7. About 74,018 shares traded. Calavo Growers, Inc. (NASDAQ:CVGW) has risen 52.39% since May 17, 2017 and is uptrending. It has outperformed by 40.84% the S&P500.

Calavo Growers, Inc. (NASDAQ:CVGW) Ratings Coverage

Among 3 analysts covering Calavo Growers (NASDAQ:CVGW), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Calavo Growers had 4 analyst reports since December 6, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, December 6 by Stephens. On Wednesday, March 21 the stock rating was maintained by Stephens with “Buy”. The firm earned “Buy” rating on Thursday, March 8 by Buckingham Research.

Calavo Growers, Inc. markets and distributes avocados, prepared avocados, and other perishable foods to food distributors, produce wholesalers, supermarkets, convenience stores, and restaurants worldwide. The company has market cap of $1.64 billion. It operates in three divisions: Fresh Products, Calavo Foods, and RFG. It has a 41.85 P/E ratio. The Fresh products segment distributes avocados and other fresh produce products; and procures avocados grown in Mexico, as well as various other commodities, including tomatoes, papayas, and pineapples.

Another recent and important Calavo Growers, Inc. (NASDAQ:CVGW) news was published by Globenewswire.com which published an article titled: “Recent Analysis Shows Lancaster Colony, Calavo Growers, Acuity Brands, Cyclacel Pharmaceuticals, Enbridge …” on May 04, 2018.

Calavo Growers, Inc. (NASDAQ:CVGW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: